Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Female mice are less affected by certain substances that alter alcohol consumption compared to male mice.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Dutasteride and finasteride can change hair growth genes, helping treat hair loss.

Gene expression differences in PFS patients suggest a potential organic cause for symptoms.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Finasteride caused breast enlargement in two men, which improved after stopping the medication.

Mutations in the androgen receptor gene cause androgen insensitivity, leading to female traits in genetically male individuals.

Anabolic-androgenic steroids can harm women's health and their offspring.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Norplant implants lower some androgen levels but don't significantly change sexual function.

Gender-affirming care greatly improves mental health for transgender and non-binary individuals.

Androgens and DHEA can help prevent breast cancer and improve health in women.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.